Gillheeney Gary S. 4

What Happened

• Gary S. Gillheeney, President & CEO and a director of Organogenesis Holdings, had a total of 271,406 shares disposed via share withholding to satisfy tax or exercise obligations on February 15, 2026. Each lot was recorded at $3.73 per share, totaling approximately $1,012,345 in value. These transactions are reported as code F (payment of exercise price or tax liability), i.e., shares were withheld rather than sold on the open market for cash.

Key Details

• Transaction date: 2026-02-15 (reported on Form 4 filed 2026-02-18)
• Individual withholding entries:
  • 24,340 shares withheld @ $3.73 = $90,788
  • 78,646 shares withheld @ $3.73 = $293,350
  • 82,815 shares withheld @ $3.73 = $308,900
  • 85,605 shares withheld @ $3.73 = $319,307
• Total: 271,406 shares withheld; total value ≈ $1,012,345
• Shares owned after transaction: not specified in the filing excerpt
• Footnote/transaction code: F — payment of exercise price or tax liability (share withholding)
• Timeliness: Filing dated 2026-02-18 for transactions on 2026-02-15 — appears to have been filed one business day late (Form 4 is typically due within two business days)

Context

• These entries reflect tax withholding (often part of an option exercise or restricted stock vesting) rather than an open-market sale. Withheld shares satisfy tax obligations and do not necessarily indicate a bearish view by the insider; they are routine administrative actions tied to equity compensation.